Human herpesvirus 8 (Kaposi sarcoma)

8,833views

Human herpesvirus 8 (Kaposi sarcoma)

pii bw2 2.0

pii bw2 2.0

Bacterial structure and functions
Staphylococcus aureus
Streptococcus pyogenes (Group A Strep)
Enterococcus
Neisseria meningitidis
Neisseria gonorrhoeae
Listeria monocytogenes
Corynebacterium diphtheriae (Diphtheria)
Bacillus anthracis (Anthrax)
Escherichia coli
Salmonella typhi (typhoid fever)
Salmonella (non-typhoidal)
Shigella
Yersinia pestis (Plague)
Yersinia enterocolitica
Klebsiella pneumoniae
Enterobacter
Bordetella pertussis (Whooping cough)
Pseudomonas aeruginosa
Vibrio cholerae (Cholera)
Haemophilus influenzae
Mycobacterium tuberculosis (Tuberculosis)
Mycobacterium leprae
Chlamydia pneumoniae
Chlamydia trachomatis
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Coxiella burnetii (Q fever)
Clostridium botulinum (Botulism)
Clostridium difficile (Pseudomembranous colitis)
Clostridium perfringens
Clostridium tetani (Tetanus)
Bacteroides fragilis
Treponema pallidum (Syphilis)
Borrelia burgdorferi (Lyme disease)
Leptospira
Candida
Mycoplasma pneumoniae
Malassezia (Tinea versicolor and Seborrhoeic dermatitis)
Aspergillus fumigatus
Cryptococcus neoformans
Mucormycosis
Sporothrix schenckii
Histoplasmosis
Blastomycosis
Coccidioidomycosis and paracoccidioidomycosis
Leishmania
Pediculus humanus and Phthirus pubis (Lice)
Sarcoptes scabiei (Scabies)
Toxoplasma gondii (Toxoplasmosis)
Babesia
Giardia lamblia
Trypanosoma cruzi (Chagas disease)
Trichomonas vaginalis
Enterobius vermicularis (Pinworm)
Toxocara canis (Visceral larva migrans)
Viral structure and functions
Adenovirus
Cytomegalovirus
Epstein-Barr virus (Infectious mononucleosis)
Herpes simplex virus
Human herpesvirus 6 (Roseola)
Human herpesvirus 8 (Kaposi sarcoma)
Varicella zoster virus
Human papillomavirus
Ebola virus
Dengue virus
Zika virus
Influenza virus
Measles virus
Respiratory syncytial virus
Coxsackievirus
Rhinovirus
HIV (AIDS)
Eastern and Western equine encephalitis virus
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Fluoroquinolones
DNA synthesis inhibitors: Metronidazole
Mechanisms of antibiotic resistance
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Azoles
Herpesvirus medications
Anatomy of the pelvic girdle

Transcript

Watch video only

Human herpesvirus 8, or HHV-8, also called Kaposi’s sarcoma-associated herpesvirus, or KSHV, belongs to the family of human gamma herpesviruses.

HHV-8 is one of the seven known oncoviruses, meaning viruses that cause cancer in people.

Specifically, HHV-8 causes Kaposi’s sarcoma, a type of cancer usually seen in individuals with AIDS.

Human herpesvirus 8 is a large double stranded linear DNA virus surrounded by an icosahedral capsid, which is a spherical protein shell made up of 20 equilateral triangular faces.

The capsid is covered by a protein layer called the tegument, and finally enclosed in an envelope, which is a lipid membrane that contains viral glycoproteins and is acquired from the nuclear membrane of host cells.

HHV-8 is transmitted through sexual contact and once in the body it uses the viral glycoproteins on its envelope to enter a wide variety of cells such as B cells, endothelial cells, macrophages and epithelial cells.

Now, the virus life cycle has two phases - a latent phase and a lytic phase.

In the latent phase, the virus just hangs out in the cell without destroying it, and expresses the viral latency-associated nuclear antigen, or LANA-1.

This may sound harmless, but LANA-1 inhibits p53, a tumor suppressor protein that prevents cancer formation.

So when LANA-1 inhibits p53, that prevents apoptosis and leads to uncontrolled cellular proliferation.

In the lytic phase, the virus starts to replicate, so its DNA gets transcribed and translated by cellular enzymes, in order to form viral proteins, which are packaged into new viruses.

When the virus enters into the lytic phase, thousands of virus particles can be made from a single cell which can destroy the cell and subsequently infect neighboring cells.

Now, the body’s immune system reacts to the infection by mounting a humoral response, where the B cells create antibodies to fight off the virus, and a cellular response, in which cytotoxic T cells work to kill the infected cells, limiting their ability to spread to other tissues.

So, in people with a healthy immune system, infection rarely occurs.

However, people who are immunocompromised, such as people with AIDS, people who have undergone an organ transplant or people who take immunosuppressive medications, are at risk for developing the disease.

Specifically, HHV-8 causes a disease called Kaposi’s sarcoma which is classified into 4 types depending on the clinical circumstances in which it develops: classic, endemic, epidemic and immunosuppression therapy-related.

So, classic Kaposi’s sarcoma usually affects older males, it’s slow growing and it usually affects the legs.

Endemic Kaposi’s sarcoma occurs in young adult males who live in Africa and can be more aggressive.

Epidemic Kaposi’s sarcoma is associated with AIDS and can affect many body parts such as skin, mouth, GI tract or lungs.

Finally, immunosuppression therapy-related Kaposi’s sarcoma affects the skin, and it usually develops following organ transplantation.

Key Takeaways

Human herpesvirus 8 (HHV-8) also known as Kaposi's sarcoma-associated herpesvirus, is a double-stranded DNA virus known to cause a type of cancer called Kaposi sarcoma. Kaposi sarcoma is most commonly found in individuals with HIV/AIDS, and generally affects the skin, mucous membranes, lymph nodes, the GI tract, and lungs.